Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > December 7, 2022
Daily News
December 7, 2022
- Man Sues PMDA over Rejected Relief Claim for “Ranitidine Caused Cancer”
December 7, 2022
- Kyowa Kirin, MEI Drop PI3Kδ Inhibitor Outside Japan after US FDA Guidance
December 7, 2022
- Lilly’s Insulin Lyumjev Gets Label Update for Pediatric Use
December 7, 2022
- Francis Vaillant to Succeed Shingo Iwamoto as Sandoz Japan President
December 7, 2022
- Kyowa Kirin Rolls Out Automated Injection Device of G-Lasta in Japan
December 7, 2022
- Ono Gets Its Hands on Equillium’s Rights to 1st-in-Class CD6 Drug
December 7, 2022
- Lilly’s Simone Thomsen to Become PhRMA Japan Chair in January
December 7, 2022
- Opdivo Tops Japan Drug Sales Ranking for 11 Months on End: Encise
December 7, 2022
- FPMAJ Poll Finds Worsening Supply Woes with 28% of Drugs Restricted or Suspended
December 7, 2022
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…